Why choosing us
We offer a high-end health service with the objective of improving our patients’ quality of life
Why choosing us
We offer a high-end
health service with
the objective of improving
our patients’ quality of life

Q2 CLINIC

Is the first international
chain of medical cannabis clinics

We offer a high-end health service founded on the doctor-patient relationship, on well-established treatments and provided by the best clinicians available. Each patient is unique, and our goal is to give each one of them the best personalized experience by taking all the time we need with them during our concierge-style appointments.
Q2 Clinic was founded with the objective of constructing a global network of high-end health practices based on the use of medicinal cannabis, a natural product that had been used by ancient cultures for its healing properties and now, through biotechnology advances, is becoming the future of medicine. Our outstanding team of professionals is led by our Chief Medical Director (CMD), Dr. Peter Grinspoon, MD, primary care physician and cannabis specialist at Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School. All of our doctors attended the Induction and Leveling Program for Professionals especially designed for Q2 Clinic and directed by Raquel Peyraube, MD, world-class Uruguayan doctor specialized in Endocannabinology.
Q2Clinic-Nuestro-Staff-Dr-Peter-Grinspoon_profile

Dr. Peter Grinspoon, M.D.

Q2 Clinic Chief Medical Director

Peter Grinspoon, M.D. is a primary care physician and cannabis specialist at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. He is a certified Health and Wellness Coach as well as a board member of the advocacy group Doctors for Cannabis Regulation. He spent two years as an Associate Director of the Massachusetts Physician Health Service, treating and monitoring physicians with addiction. He is the author of the memoir Free Refills: A Doctor Confronts His Addiction (Hachette, 2016), which was optioned for television production by MarVista Entertainment. He was the expert witness in the successful citizens’ 2019 lawsuit against the Massachusetts “Vape Ban” and a special consultant on addiction issues to Jagged Little Pill’’s pre-Broadway run when it was at the American Repertory Theater. He was named by Boston Resilient, a Harvard Medical School-based tribute to addiction-recovery leaders, a “Hero in Recovery.”

Dr. Grinspoon is a widely recognized expert on cannabis science and drug policy. He has been on NPR’s All Things Considered as well as national television shows including NBC Nightly News, C-SPAN’s Washington Journal, Fox and Friends and Fox News. He is quoted frequently in the national press, including such venues as People, New York Magazine (The Cut), the Washington Post, USA Today, the British Medical Journal, the Wall Street Journal, the Chicago Tribune, and the Boston Globe. His writing has been published in The Nation, the Los Angeles Times and Narrative Inquiry in Bioethics.

He is a Contributing Editor to Harvard Health Publications, where several of his blogs on medical marijuana and CBD have received more than 200,000 hits each. His Harvard Health writings have reached millions of readers, have been widely referenced in the national media and have been cited in congressional testimony. He is a TedX speaker. According to Wikipedia, Dr. Grinspoon is “an authority on virtually all aspects of cannabis, including recreational and medical usages, as well as political issues and social history”.